The Fertility Preservation Program is a multidisciplinary working group that includes key stake holders at Magee-Womens Research Institute, Magee-Womens Hospital of UPMC and Children’s Hospital of Pittsburgh of UPMC. We have established a dedicated phone line (412-641-7475) that patients and their physicians can call to learn about the reproductive side effects of their treatments and options for preserving their fertility. This is a discussion that needs to happen before toxic therapies are initiated and fertility is irreversibly destroyed.

Adult men and women can freeze eggs, sperm or embryos prior to treatment, and these standard services are available in the Center for Fertility and Reproductive Endocrinology at Magee-Womens Hospital. There are no standard options to preserve the fertility of boys and girls who are not yet producing mature eggs or sperm. For these young patients, we are approved to freeze testicular or ovarian tissue that might be used in the future to restore fertility when experimental techniques emerge from the research pipeline.

Through the Center for Fertility and Reproductive Endocrinology at Magee-Womens Hospital, we provide the following services for patients ranging from prepuberty to adulthood:

  • semen cryopreservation
  • embryo cryopreservation
  • embryo cryopreservation using donor sperm
  • oocyte cryopreservation (in coordination with the Institutional Review Board at the University of Pittsburgh)
  • testicular tissue freezing (in coordination with the Institutional Review Board at the University of Pittsburgh)
  • ovarian tissue freezing (in coordination with the Institutional Review Board at the University of Pittsburgh)